---
figid: PMC4491676__cancers-07-00648-g003
figtitle: PP2A as a promoter of carcinogenesis
organisms:
- Drosophila melanogaster
- Caenorhabditis elegans
- Mylabris cichorii
- Mylabris phalerata
- Mus musculus
- Rattus norvegicus
- Oryctolagus cuniculus
- Human immunodeficiency virus 1
- Ovis aries
- Betapolyomavirus macacae
- Homo sapiens
- NA
organisms_ner:
- Drosophila melanogaster
- Mus musculus
- Homo sapiens
- Rattus norvegicus
pmcid: PMC4491676
filename: cancers-07-00648-g003.jpg
figlink: /pmc/articles/PMC4491676/figure/cancers-07-00648-f003/
number: F3
caption: PP2A as a promoter of carcinogenesis. The PP2A holoenzymes containing B55α
  and B55δ play a positive regulatory role in the MAP kinase pathway through direct
  dephosphorylation of RAF1 on Ser259. The PP2A holoenzyme containing B55α also dephophorylates
  KSR1 on Ser392 and RAF on Ser295 to activate ERK [,]. Inhibition of PP2A by Cantharidin
  promotes apoptosis in cancer cells by mediating the prolonged phosphorylation of
  I κ B kinase α (IKK) and activation of NFκB []. Cantharidin also induces apoptosis
  by blocking PP2A mediated activation of the MAP kinase pathway [,]. Inhibition of
  PP2A using okadaic acid increases the sensitivity of breast cancer cells to the
  drug lapatinib which has an anti-proliferative effect on cells [].
papertitle: 'PP2A: The Wolf in Sheep’s Clothing?.'
reftext: Maeve Kiely, et al. Cancers (Basel). 2015 Jun;7(2):648-669.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9227269
figid_alias: PMC4491676__F3
figtype: Figure
redirect_from: /figures/PMC4491676__F3
ndex: c6edf832-df0b-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4491676__cancers-07-00648-g003.html
  '@type': Dataset
  description: PP2A as a promoter of carcinogenesis. The PP2A holoenzymes containing
    B55α and B55δ play a positive regulatory role in the MAP kinase pathway through
    direct dephosphorylation of RAF1 on Ser259. The PP2A holoenzyme containing B55α
    also dephophorylates KSR1 on Ser392 and RAF on Ser295 to activate ERK [,]. Inhibition
    of PP2A by Cantharidin promotes apoptosis in cancer cells by mediating the prolonged
    phosphorylation of I κ B kinase α (IKK) and activation of NFκB []. Cantharidin
    also induces apoptosis by blocking PP2A mediated activation of the MAP kinase
    pathway [,]. Inhibition of PP2A using okadaic acid increases the sensitivity of
    breast cancer cells to the drug lapatinib which has an anti-proliferative effect
    on cells [].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Ras64B
  - Ras85D
  - wrd
  - wdb
  - mts
  - tws
  - Pp2A-29B
  - Raf
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - AIMP2
  - p38a
  - Hrb87F
  - p38c
  - IKKepsilon
  - key
  - IKKbeta
  - bsk
  - Dif
  - dl
  - Rel
  - Hras
  - Kras
  - Rem1
  - Ppp2ca
  - Ppp2r1a
  - Zhx2
  - Mink1
  - Mdk
  - Ephb2
  - Mapk1
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Mapk8
  - Nfkb1
  - KRAS
  - HRAS
  - NRAS
  - PTPA
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MINK1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - CRK
  - MAPK14
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - MAPK8
  - MAPK9
  - MAPK10
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - Ephb1
  - Rela
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
---
